Hepatitis E natural history: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:


===Acute Hepatitis E===
===Acute Hepatitis E===
The clinical course of acute hepatitis E progresses acceding to the following phases:<ref name="pmid22549046">{{cite journal| author=Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J et al.| title=Hepatitis E. | journal=Lancet | year= 2012 | volume= 379 | issue= 9835 | pages= 2477-88 | pmid=22549046 | doi=10.1016/S0140-6736(11)61849-7 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22549046  }} </ref><ref name="pmid18617784">{{cite journal| author=Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W et al.| title=Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. | journal=Eur J Gastroenterol Hepatol | year= 2008 | volume= 20 | issue= 8 | pages= 784-90 | pmid=18617784 | doi=10.1097/MEG.0b013e3282f5195a | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18617784  }} </ref><ref name="pmid18462508">{{cite journal| author=Borgen K, Herremans T, Duizer E, Vennema H, Rutjes S, Bosman A et al.| title=Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004 - 2006. | journal=BMC Infect Dis | year= 2008 | volume= 8 | issue=  | pages= 61 | pmid=18462508 | doi=10.1186/1471-2334-8-61 | pmc=PMC2413240 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18462508  }} </ref><ref name="pmid21453549">{{cite journal| author=Zhang S, Wang J, Yuan Q, Ge S, Zhang J, Xia N et al.| title=Clinical characteristics and risk factors of sporadic Hepatitis E in central China. | journal=Virol J | year= 2011 | volume= 8 | issue=  | pages= 152 | pmid=21453549 | doi=10.1186/1743-422X-8-152 | pmc=PMC3082222 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21453549  }} </ref>
*Incubation period
**Lasts 3 to 8 weeks
*Prodromal phase
*Symptomatic period
**Lasts days to weeks


===Chronic Hepatitis E===
===Chronic Hepatitis E===

Revision as of 20:30, 25 August 2014

Hepatitis E Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Hepatitis E from other Diseases

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Hepatitis E natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis E natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis E natural history

CDC on Hepatitis E natural history

Hepatitis E natural history in the news

Blogs on Hepatitis E natural history

Directions to Hospitals Treating Hepatitis E

Risk calculators and risk factors for Hepatitis E natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Natural History

Hepatitis E may be classified in acute and chronic disease.[1]

Acute Hepatitis E

The clinical course of acute hepatitis E progresses acceding to the following phases:[2][3][4][5]

  • Incubation period
    • Lasts 3 to 8 weeks
  • Prodromal phase
  • Symptomatic period
    • Lasts days to weeks

Chronic Hepatitis E

Complications

Prognosis

In most immunocompetent patients, hepatitis E is self-limited. In these cases the prognosis is often good. Immunocompromised patients, and those with end-stage liver disease are at higher risk of developing chronic hepatitis and other complications. This last group of patients have a poor prognosis.[2]

References

  1. Hoofnagle JH, Nelson KE, Purcell RH (2012). "Hepatitis E." N Engl J Med. 367 (13): 1237–44. doi:10.1056/NEJMra1204512. PMID 23013075.
  2. 2.0 2.1 Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J; et al. (2012). "Hepatitis E." Lancet. 379 (9835): 2477–88. doi:10.1016/S0140-6736(11)61849-7. PMID 22549046.
  3. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W; et al. (2008). "Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease". Eur J Gastroenterol Hepatol. 20 (8): 784–90. doi:10.1097/MEG.0b013e3282f5195a. PMID 18617784.
  4. Borgen K, Herremans T, Duizer E, Vennema H, Rutjes S, Bosman A; et al. (2008). "Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004 - 2006". BMC Infect Dis. 8: 61. doi:10.1186/1471-2334-8-61. PMC 2413240. PMID 18462508.
  5. Zhang S, Wang J, Yuan Q, Ge S, Zhang J, Xia N; et al. (2011). "Clinical characteristics and risk factors of sporadic Hepatitis E in central China". Virol J. 8: 152. doi:10.1186/1743-422X-8-152. PMC 3082222. PMID 21453549.

Template:WS Template:WH